economic news

Texas slides down the list of best U.S. state economies for 2025

Getty Images

After riding high among the top five best state economies in 2024, Texas' robust economy may be showing some cracks. Texas now ranks as the state with the eighth best economy, four spots lower than last year's ranking, according to a new WalletHub report.

WalletHub's experts ranked all 50 states and the District of Columbia across 28 metrics to measure each state's economic activity and health and its "innovation potential."

Massachusetts moved up two spots from last year to claim the No. 1 best state economy title for 2025, followed by Utah (No. 2) and Washington (No. 3). Texas was surpassed by No. 4-ranking California, as well as New Hampshire (No. 5), North Carolina (No. 6), and Idaho (No. 7).

This is how Texas fared across the three major categories in the study:

No. 4 – Economic activity (down from No. 2)
No. 11 – Economic health (down from No. 7)
No. 24 – Innovation potential (unchanged)

Texas ranked No. 1 with the most exports per capita in a three-way tie with Louisiana and Kentucky, the report found.

The Lone Star State prides itself on its business-friendliness, and cities like Houston boast some of the most innovative companies in the nation. Texas also ranked 13th in WalletHub's separate study of the most and least innovative states for 2025.

WalletHub analyst Chip Lupo says the states that have the best economies are often those that invest in new businesses, technology, and more. The report also suggests low unemployment rates and high wages are among the many factors that can help Texas residents be successful while also boosting the state economy.

"A strong state economy doesn’t guarantee success for the state’s residents, but it certainly makes financial success more attainable," Lupo said.

The states with the worst economies in 2025, according to WalletHub, are Hawaii (No. 49), West Virginia (No. 50), and Iowa (No. 51).

texas economy innovation wallethub reports

breaking ground

Pharmacy giant Bristol Myers Squibb to build $2.3B Houston factory

Bristol Myers Squibb Houston factory rendering

Courtesy of Bristol Myers Squibb

The 60,000-square-foot facility is expected to open in 2030.

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

---

This story was first published on our sister site InnovationMap.